SCHEMBL17972750

SCHEMBL17972750

CCOC(=O)COc1ccc(C)nc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 3/20 0.47
NPSR1 Q6W5P4 3/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 1/20 0.47
CASP1 P29466 1/20 0.47
KMT2A Q03164 1/20 0.47
HSD17B10 Q99714 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
S1PR4 O95977 1/20 0.46
GAA P10253 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
POLB P06746 1/20 0.44
PABPC1 P11940 1/20 0.44
APOBEC3A P31941 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
ESR1 P03372 1/20 0.43
ABCB1 P08183 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14570536 0.84 S1PR4 (0.49) MEN1KMT2AS1PR4
SCHEMBL3710075 0.83 PTGDR2 (0.49) ALDH1A1KDM4EHPGDSMN1; SMN2S1PR4
SCHEMBL12145951 0.82 S1PR4 (0.44) ALDH1A1KDM4ENPSR1HPGDMEN1
SCHEMBL17980858 0.82 ALDH1A1 (0.44) ALDH1A1KDM4ENPSR1HPGDMEN1
SCHEMBL5533491 0.82 ALDH1A1 (0.47) ALDH1A1KDM4ENPSR1HPGDMEN1
SCHEMBL20116703 0.80 S1PR4 (0.55) KDM4EHPGDMEN1KMT2AHSD17B10
SCHEMBL16900169 0.77 ALDH1A1 (0.62) ALDH1A1KDM4ENPSR1MEN1KMT2A
SCHEMBL13739997 0.75 PTGDR2 (0.60) ALDH1A1KDM4ENPSR1HPGDMEN1
SCHEMBL16559854 0.75 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL13739761 0.74 PDE10A (0.44) ALDH1A1KDM4ENPSR1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160221971-A1 DI-MACROCYCLES LUMIPHORE, INC. (US) 2016-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221971-A1 DI-MACROCYCLES DLD, NDC1, MCL1 ALDH1A1 1827/4885KDM4E 4621/4885NPSR1 1178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.